Drug Discovery at the Institute is made up of many scientists working together as a team to design, test and develop molecules that will eventually become drugs for psychiatric diseases.
Drug discovery & development: translational medicine
From compound design and creation by medicinal chemistry to testing candidates for therapeutic effect in assay development and pharmacokinetics, drug discovery is a true meld of chemistry and biology. In this arena, we have both disciplines working together towards a common goal: translational medicine.
Read more about our research in medicinal chemistry, in vivo pharmacology and assay development below.
Working to improve current therapies and develop new treatments for patients with schizophrenia and related brain disorders.
LIBD Speaker Series: Bryan W. Luikart, Ph.D.
Understanding the Neurobiological Basis of Autism Using PTEN as a Genetic Model Bryan W. Luikart, Ph.D. Assistant Professor Department of Molecular and Systems Biology Geisel School of Medicine at Dartmouth When: September 26 2:00pm-3:00pm Where: The Lieber Institute for Brain […]